Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
---|
07/09/1998 | WO1998029097A1 Methods and compositions for improved bioavailability of bioactive agents for mucosal delivery |
07/09/1998 | WO1998029096A1 Aerosolized hydrophobic drug |
07/09/1998 | WO1998028978A1 Structured glycerols and structured phosphatides |
07/09/1998 | WO1998013069A3 Fluorinated copolymeric pharmaceutical adjuncts |
07/09/1998 | WO1998007745A3 Compositions and methods for treating infections using analogues of indolicidin |
07/09/1998 | DE3645269C2 Sterile, pyrogen-free, anthracycline glycoside soln |
07/09/1998 | CA2650204A1 Pharmaceutical preparations of glutathione and methods of administration thereof |
07/09/1998 | CA2605707A1 Pharmaceutical preparations of glutathione and methods of administration thereof |
07/09/1998 | CA2276573A1 Nanoscale particles synthesized within an assembled virion |
07/09/1998 | CA2276394A1 Poly(diallylamine)-based bile acid sequestrants |
07/09/1998 | CA2276091A1 Cell membrane-directed drugs |
07/09/1998 | CA2275769A1 Extremely flexible plaster acting dermally or transdermally, and method for producing same |
07/09/1998 | CA2275502A1 Methods and compositions for improved bioavailability of bioactive agents for mucosal delivery |
07/09/1998 | CA2275455A1 Conjugates of a particle vector and oligonucleotides, process for their preparation, and pharmaceutical compositions containing them |
07/08/1998 | EP0852243A1 Polyethylene oxides having saccharide residue at one end and different functional group at another end, and process for producing the same |
07/08/1998 | EP0852143A1 Stable vitamin c preparation |
07/08/1998 | EP0851925A1 Human growth hormone variants |
07/08/1998 | EP0851871A1 Inhibition of tumor growth |
07/08/1998 | EP0851768A2 Interactive molecular conjugates |
07/08/1998 | EP0851767A1 Transcytosis vehicles and enhancers for drug delivery |
07/08/1998 | EP0851764A1 Heat shock protein-based vaccines and immunotherapies |
07/08/1998 | EP0851755A1 Antiseptic skin care composition and method for making same |
07/08/1998 | EP0851754A1 Nanoparticles in photodynamic therapy |
07/08/1998 | EP0851753A1 Aerosol compositions |
07/08/1998 | EP0626857B1 Improved peritoneal dialysis solutions with polypeptides |
07/08/1998 | EP0611306B1 Hemoglobins as drug delivery agents |
07/08/1998 | CN1187217A Botulinum toxin derivatives able to modify peripheral sensory afferent functions |
07/08/1998 | CN1187212A Polyethylene oxides having saccharide residue at one end and different functional group at another end, and process for producing the same |
07/08/1998 | CN1187203A Method for treatment of corticosteroid induced osteopenia |
07/08/1998 | CN1187140A Device for trandermal electrotransport delivery of fentanyl and sufentanil |
07/08/1998 | CN1187137A Novel targeted compositions for diagnostic and therapeutic use |
07/08/1998 | CN1187134A Composition for sustained release of non-aggregated erythropoietin |
07/08/1998 | CN1187126A Pharmaceutical formulations of highly lipophilic camptothecin devivatives |
07/08/1998 | CN1187125A Oral pharmaceutical composition of piperidinoalkanol compounds in solution form |
07/08/1998 | CN1187120A Composition for sustained release of human growth hormone |
07/08/1998 | CN1187119A Peptide/protein suspension formulations |
07/08/1998 | CN1039015C Polyethylene glycol-interferon conjugates |
07/07/1998 | US5777092 Heteroatomic oligonucleoside linkages |
07/07/1998 | US5777078 Inactive staphylococcal a-toxin protein |
07/07/1998 | US5776986 Composition containing retinal |
07/07/1998 | US5776968 Therapeutic uses of melanin |
07/07/1998 | US5776926 Cefixime composition |
07/07/1998 | US5776912 Lipophilic oligosaccharide antibiotic compositions |
07/07/1998 | US5776908 Cationic compounds used as carriers for delivery of macromolecules |
07/07/1998 | US5776891 Polyester |
07/07/1998 | US5776886 Intravaginal preparation containing physiologically active peptide |
07/07/1998 | US5776885 Polylactide polymer and polymer of lactic acid and glycolic acid and pamoate salt |
07/07/1998 | US5776505 Pharmaceutical combination preparation comprising ketoprofen |
07/07/1998 | US5776501 Coating base for solid enteric pharmaceutical preparations |
07/07/1998 | US5776494 Pharmaceuticals compositions containing gellants in the form of alkyl amides of di-and tri-carboxylic acids |
07/07/1998 | US5776492 Rapidly disintegrating medicinal form of tramadol or a tramadol salt |
07/07/1998 | US5776485 Nonionic polyacrylamide with high molecular weight for drug delivery |
07/07/1998 | US5776484 Analgesic anti-inflammatory adhesive plaster |
07/07/1998 | US5776468 Vaccine compositions containing 3-0 deacylated monophosphoryl lipid A |
07/07/1998 | US5776462 Pogostemon cablin extract for inhibiting H. influenzae adhesion and treating otitis media or sore throat |
07/07/1998 | US5776458 Antitumor agents |
07/07/1998 | US5776456 Administering a polypeptide |
07/07/1998 | US5776445 Ophthalmic delivery system |
07/07/1998 | US5776431 Aspirin and citric acids with metal salts |
07/07/1998 | US5776429 Method of preparing gas-filled microspheres using a lyophilized lipids |
07/07/1998 | US5776427 Methods for targeting the vasculature of solid tumors |
07/07/1998 | US5776095 Pretargeting noncanerous cells or tissues with a cytoprotective agents before therapy with radiation or anticarcinogenic agents |
07/07/1998 | US5776094 Method and kit for imaging and treating organs and tissues |
07/07/1998 | US5776093 Method for imaging and treating organs and tissues |
07/07/1998 | CA2111932C Quick-drying gel-type disinfectant for hands and fingers |
07/02/1998 | WO1998028417A1 Nucleic acid constructs and uses thereof for direct nucleic acid incorporation into cells |
07/02/1998 | WO1998028357A1 Biodegradable targetable microparticle delivery system |
07/02/1998 | WO1998028355A1 Cationic film-forming polymer compositions containing same, and uses thereof, including topical delivery system and method of delivering agents to the skin and hair |
07/02/1998 | WO1998028336A1 Polysaccharide-peptide derivatives |
07/02/1998 | WO1998028011A1 Compositions containing lipophilic oligosaccharide antibiotic and albumin |
07/02/1998 | WO1998028010A2 Use of moieties for binding to hyaluronan and icam-1 |
07/02/1998 | WO1998028009A1 Pharmaceutical compositions for freeze drying |
07/02/1998 | WO1998028008A1 Pharmaceutical compositions containing gellants in the form of alkyl amides of di- and tri-carboxylic acids |
07/02/1998 | WO1998028007A1 Stable liquid interferon formulations |
07/02/1998 | WO1998028000A1 Stabilizers for lyophilized vaccines |
07/02/1998 | WO1998027972A2 Anti-amyloidogenic agents |
07/02/1998 | WO1998027968A1 Novel topical formulation of anti-inflammatory drugs for the treatment of localized pain |
07/02/1998 | WO1998027966A2 Encapsulated cells producing antibodies |
07/02/1998 | WO1998027965A1 Pharmaceutical composition with base of rhein or diacerhein with improved biological availability |
07/02/1998 | WO1998027963A2 Gel composition and methods |
07/02/1998 | WO1998027962A2 Injectable depot gel composition and method of preparing the composition |
07/02/1998 | WO1998027961A2 Antitussive drugs delivered by partially coated ion exchange resins |
07/02/1998 | WO1998027960A2 A nitroimidazole gel composition |
07/02/1998 | WO1998027959A2 New aqueous medicament preparations for the production of propellent gas-free aerosols |
07/02/1998 | WO1998017315A3 Permeation enhancers for transdermal drug delivery compositions, devices, and methods |
07/02/1998 | CA2591581A1 Gel composition and methods |
07/02/1998 | CA2275902A1 Palatable hydroxypropyl methylcellulose ether powder with specified particle size |
07/02/1998 | CA2275892A1 Nucleic acid constructs and uses thereof for direct nucleic acid incorporation into cells |
07/02/1998 | CA2275567A1 Cationic film-forming polymer compositions containing same, and uses thereof, including topical delivery system and method of delivering agents to the skin and hair |
07/02/1998 | CA2275483A1 Polysaccharide-peptide derivatives |
07/02/1998 | CA2275429A1 A nitroimidazole gel composition |
07/02/1998 | CA2275373A1 Compositions containing lipophilic oligosaccharide antibiotic and albumin |
07/02/1998 | CA2274755A1 Stabilizers for lyophilized vaccines |
07/02/1998 | CA2269679A1 Antitussive drugs delivered by partially coated ion exchange resins |
07/01/1998 | EP0850947A1 Crystalline powdery saccharide, its preparation and uses |
07/01/1998 | EP0850651A2 Method of applying drug-release coatings |
07/01/1998 | EP0850634A1 Preservative system and its use in a cosmetic or pharmaceutical composition |
07/01/1998 | EP0850408A1 METHOD FOR MEASURING NITROSYL (FeII)-HEMOGLOBIN |
07/01/1998 | EP0850262A1 Selectively functionalizable desdendrimers |
07/01/1998 | EP0850251A1 Nitrosated hemoglobins and therapeutic uses therefor |